Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Oocytes Recipients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01137461 |
Recruitment Status :
Completed
First Posted : June 4, 2010
Last Update Posted : April 14, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Infertility | Procedure: ultrasound-guided embryo transfer | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 330 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Evaluation of Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Recipients of Oocytes. A Single-centre, Randomized Clinical Trial. |
Study Start Date : | June 2010 |
Actual Primary Completion Date : | October 2010 |
Actual Study Completion Date : | October 2010 |

Arm | Intervention/treatment |
---|---|
abdominal ultrasound
traditional technique
|
Procedure: ultrasound-guided embryo transfer
Embryo transfer in oocyte recipients |
transvaginal ultrasound
new technique
|
Procedure: ultrasound-guided embryo transfer
Embryo transfer in oocyte recipients |
- Clinical pregnancy rate [ Time Frame: 40 days after embryo transfer ]Evidence of gestational sac by transvaginal ultrasound

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Oocyte recipients.
- Uterus without previously detected anomalies.
- Patients able to understand the study requirements who want to participate during all its duration and that have signed the informed consent.
Exclusion Criteria:
- Turner syndrome, Black race (significantly lower implantational rates)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01137461
Spain | |
Clinica EUGIN | |
Barcelona, Spain, 08029 |
Principal Investigator: | Daniel Bodri | Clinica EUGIN |
Publications of Results:
Responsible Party: | Dr. Daniel Bodri / Principal investigator, Clinica EUGIN |
ClinicalTrials.gov Identifier: | NCT01137461 History of Changes |
Other Study ID Numbers: |
TATV |
First Posted: | June 4, 2010 Key Record Dates |
Last Update Posted: | April 14, 2011 |
Last Verified: | April 2011 |
Keywords provided by Fundació Privada Eugin:
Female infertility with indication of oocyte reception |
Additional relevant MeSH terms:
Infertility Genital Diseases, Male Genital Diseases, Female |